Profile data is unavailable for this security.
About the company
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
- Revenue in SEK (TTM)1.34bn
- Net income in SEK227.77m
- Incorporated1988
- Employees458.00
- LocationRaySearch Laboratories AB (publ)Eugeniavagen 18CSTOCKHOLM 104 30SwedenSWE
- Phone+46 851053000
- Fax+46 854506139
- Websitehttps://www.raysearchlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medistim ASA | 628.05m | 133.78m | 3.32bn | 154.00 | 24.78 | 8.43 | 20.95 | 5.29 | 7.79 | 7.79 | 36.56 | 22.91 | 1.25 | 0.7679 | 9.67 | 4,341,637.00 | 26.72 | 21.98 | 33.09 | 27.19 | 81.21 | 78.66 | 21.30 | 20.32 | 2.03 | -- | 0.0484 | 85.04 | 6.88 | 9.12 | 0.0087 | 8.11 | 12.53 | 16.89 |
| CellaVision AB | 758.97m | 153.08m | 3.66bn | 236.00 | 23.90 | 4.12 | 19.02 | 4.82 | 6.42 | 6.42 | 31.82 | 37.21 | 0.7201 | 2.02 | 6.80 | -- | 14.52 | 14.71 | 16.22 | 16.96 | 68.50 | 68.38 | 20.17 | 19.85 | 2.97 | 25.88 | 0.0281 | 41.97 | 4.94 | 9.99 | 8.78 | 11.34 | 20.76 | 29.67 |
| COLTENE Holding AG | 2.80bn | 166.38m | 3.82bn | 1.18k | 22.96 | 3.63 | 15.60 | 1.37 | 2.40 | 2.40 | 40.22 | 15.13 | 1.31 | 1.34 | 6.40 | 204,684.50 | 7.80 | 10.59 | 14.26 | 18.43 | 66.11 | 62.19 | 5.95 | 7.64 | 0.7043 | 7.62 | 0.3606 | 85.66 | 3.06 | -1.79 | 71.31 | 0.4306 | -15.45 | 10.76 |
| IVF Hartmann Holding AG | 1.85bn | 221.06m | 4.04bn | 309.00 | 18.31 | 2.39 | 14.38 | 2.18 | 7.92 | 7.92 | 66.39 | 60.57 | 0.8964 | 3.28 | 7.88 | 526,221.10 | 10.69 | 7.90 | 12.91 | 9.68 | 55.71 | 54.06 | 11.93 | 9.13 | 3.79 | -- | 0.0042 | 48.54 | 7.33 | 2.85 | 34.02 | 10.78 | -28.94 | 19.92 |
| Ion Beam Applications SA | 6.32bn | 180.06m | 4.94bn | 2.10k | 27.16 | 3.80 | 15.84 | 0.7827 | 0.5677 | 0.5677 | 20.17 | 4.06 | 0.9756 | 2.73 | 3.28 | 281,693.60 | 2.78 | 1.50 | 12.03 | 4.64 | 31.21 | 34.39 | 2.85 | 2.15 | 0.6209 | 7.41 | 0.3631 | 70.81 | 6.75 | 12.01 | 201.57 | 3.99 | 7.69 | 25.86 |
| Revenio Group Oyj | 1.16bn | 184.26m | 5.26bn | 247.00 | 28.44 | 4.31 | 22.76 | 4.52 | 0.654 | 0.654 | 4.12 | 4.31 | 0.7515 | 3.05 | 7.26 | 444,129.60 | 11.92 | 14.00 | 14.23 | 17.40 | 70.92 | 70.95 | 15.86 | 19.38 | 1.63 | 9.66 | 0.0969 | -- | 5.97 | 12.43 | -5.93 | 5.42 | 22.19 | -- |
| Lumibird SA | 2.29bn | 113.60m | 5.54bn | 1.07k | 48.80 | 2.62 | 17.20 | 2.42 | 0.4775 | 0.4775 | 9.61 | 8.90 | 0.5077 | 0.9593 | 4.42 | 202,198.50 | 2.52 | 2.51 | 3.11 | 3.17 | 63.89 | 61.89 | 4.97 | 4.90 | 1.64 | 3.16 | 0.4583 | 0.00 | 1.75 | 13.34 | -20.08 | -8.38 | 15.27 | -- |
| medmix AG | 5.44bn | -67.41m | 5.59bn | 2.67k | -- | 1.12 | 9.88 | 1.03 | -0.1696 | -0.1696 | 11.60 | 10.39 | 0.4707 | 3.56 | 5.86 | 174,403.90 | -0.4927 | 1.27 | -0.6199 | 1.55 | 34.52 | 35.24 | -1.05 | 2.65 | 1.10 | 1.87 | 0.4268 | 140.79 | -0.5549 | 2.84 | -2,566.67 | -- | 6.02 | -- |
| RaySearch Laboratories AB (publ) | 1.34bn | 227.77m | 5.71bn | 458.00 | 27.89 | 6.45 | 11.01 | 4.25 | 6.65 | 6.65 | 39.25 | 28.74 | 0.6584 | 6.25 | 2.93 | 2,935,074.00 | 11.16 | 5.26 | 16.21 | 7.77 | 92.42 | 91.01 | 16.94 | 9.70 | 1.66 | 64.92 | 0.2861 | 52.38 | 12.77 | 15.58 | 11.93 | -- | 0.2213 | -- |
| Advanced Medical Solutions Group plc | 2.68bn | 111.11m | 5.80bn | 1.50k | 52.05 | 1.86 | 15.68 | 2.16 | 0.0417 | 0.0417 | 1.01 | 1.17 | 0.5758 | 2.09 | 5.57 | 137,690.00 | 2.38 | 5.09 | 2.63 | 5.52 | 52.19 | 55.06 | 4.14 | 11.15 | 1.55 | 3.88 | 0.2428 | 33.47 | 40.66 | 11.64 | -55.35 | -17.81 | 8.36 | 10.90 |
| Xvivo Perfusion AB | 812.17m | 25.16m | 5.83bn | 198.00 | 232.32 | 2.76 | 61.14 | 7.18 | 0.7968 | 0.7968 | 25.76 | 67.10 | 0.34 | 0.8939 | 6.13 | 4,101,844.00 | 1.05 | 3.28 | 1.12 | 3.52 | 73.81 | 73.86 | 3.10 | 10.87 | 3.68 | 1.83 | 0.0557 | 0.00 | -1.25 | 35.19 | -85.39 | -- | -- | -- |
| Synektik SA | 1.33bn | 237.92m | 6.35bn | 203.00 | 26.68 | 11.33 | 23.68 | 4.79 | 11.09 | 9.20 | 61.80 | 26.12 | 1.22 | 11.18 | 3.60 | -- | 21.96 | 20.11 | 36.10 | 32.67 | 34.98 | 31.40 | 17.95 | 13.60 | 1.41 | 42.09 | 0.153 | -- | 9.16 | 40.29 | 51.58 | 70.02 | 28.82 | -- |
| Arjo AB (publ) | 11.00bn | 334.00m | 6.86bn | 6.94k | 22.02 | 0.9862 | 4.81 | 0.6238 | 1.23 | 1.23 | 40.39 | 27.38 | 0.704 | 4.92 | 6.22 | 1,584,702.00 | 2.14 | 3.26 | 2.91 | 4.80 | 42.59 | 43.42 | 3.04 | 4.78 | 0.8494 | 4.19 | 0.4179 | 48.74 | -2.59 | 3.92 | -32.93 | -8.68 | -- | 2.25 |
| Gerresheimer AG | 23.83bn | 247.27m | 7.28bn | 13.54k | 29.42 | 0.4901 | 2.46 | 0.3053 | 0.676 | 0.676 | 65.15 | 40.59 | 0.5455 | 3.73 | 7.85 | 185,328.90 | 0.6341 | 3.30 | 0.8716 | 4.68 | 26.89 | 30.04 | 1.16 | 5.84 | 0.5214 | 2.08 | 0.6022 | 41.29 | 2.28 | 7.90 | -5.52 | 6.32 | 17.58 | -49.35 |
| Paul Hartmann AG | 25.70bn | 863.12m | 8.29bn | 10.09k | 9.54 | 0.6635 | 4.06 | 0.3224 | 22.95 | 22.95 | 682.93 | 330.05 | 1.16 | 1.97 | 5.54 | 240,745.70 | 4.12 | 4.21 | 5.45 | 5.79 | 59.56 | 57.30 | 3.56 | 3.35 | 1.11 | 14.11 | 0.2465 | 37.95 | 2.32 | 1.95 | 281.58 | 13.23 | 10.08 | 2.71 |
| GVS SpA | 4.47bn | 242.13m | 8.38bn | 4.23k | 31.64 | 1.83 | 11.63 | 1.87 | 0.1323 | 0.1323 | 2.35 | 2.28 | 0.475 | 2.02 | 7.01 | 99,768.77 | 2.57 | 6.01 | 3.33 | 8.53 | 56.11 | 57.98 | 5.41 | 11.16 | 0.7567 | 2.40 | 0.4234 | -- | 0.8959 | 13.51 | 144.52 | 0.1729 | 23.38 | -- |
Data as of Feb 13 2026. Currency figures normalised to RaySearch Laboratories AB (publ)'s reporting currency: Swedish Krona SEK
31.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Swedbank Robur Fonder ABas of 19 Mar 2025 | 2.06m | 6.69% |
| Premier Fund Managers Ltd.as of 31 Oct 2025 | 1.30m | 4.22% |
| Andra AP-fondenas of 31 Dec 2024 | 1.22m | 3.96% |
| Financi�re de l'�chiquier SAas of 31 Mar 2025 | 1.03m | 3.34% |
| Deka Investment GmbHas of 30 Sep 2025 | 1.02m | 3.30% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 813.76k | 2.64% |
| Herald Investment Management Ltd.as of 31 Dec 2024 | 690.89k | 2.24% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 601.54k | 1.95% |
| Amundi Asset Management SASU (Investment Management)as of 02 Feb 2026 | 456.80k | 1.48% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Nov 2025 | 446.44k | 1.45% |
More ▼
Data from 30 Sep 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
